Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Diamant

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Diabetes, Obesity & Metabolism|June 23, 2015
Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humansL van Bloemendaal, D J Veltman, J S Ten Kulve, et al.
Diabetes Research and Clinical Practice|May 13, 2019
Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trialM H A Muskiet, M C Bunck, R J Heine, et al.
Diabetes, Obesity & Metabolism|December 8, 2015
Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trialM M Smits, L Tonneijck, M H A Muskiet, et al.
Annals of the Rheumatic Diseases|November 19, 2009
Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritisI C van Eijk, M E Tushuizen, A Sturk, et al.
The Journal of Clinical Endocrinology and Metabolism|November 19, 2010
Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolismN J van der Zijl, G H Goossens, C C M Moors, et al.
Diabetologia|May 13, 2011
Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trialD H van Raalte, M Brands, N J van der Zijl, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 9, 2018
Influence of prednisolone on parameters of de novo lipogenesis and indices for stearoyl-CoA- and Δ6- desaturase activity in healthy males: A Post-hoc analysis of a randomized, placebo-controlled, double-blind trialI G Pranger, D H van Raalte, M Brands, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 29, 2014
Diabetes-specific emotional distress in people with Type 2 diabetes: a comparison between primary and secondary careC H Stoop, G Nefs, V J Pop, et al.
Diabetologia|February 14, 2013
Effects of induced hyperinsulinaemia with and without hyperglycaemia on measures of cardiac vagal controlM Berkelaar, E M W Eekhoff, A M C Simonis-Bik, et al.
The Journal of Clinical Endocrinology and Metabolism|November 17, 2009
Pioglitazone compared with metformin increases pericardial fat volume in patients with type 2 diabetes mellitusJ T Jonker, H J Lamb, R W van der Meer, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Diabetes, Obesity & Metabolism|June 23, 2015
Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humansL van Bloemendaal, D J Veltman, J S Ten Kulve, et al.
Diabetes Research and Clinical Practice|May 13, 2019
Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trialM H A Muskiet, M C Bunck, R J Heine, et al.
Diabetes, Obesity & Metabolism|December 8, 2015
Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trialM M Smits, L Tonneijck, M H A Muskiet, et al.
Annals of the Rheumatic Diseases|November 19, 2009
Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritisI C van Eijk, M E Tushuizen, A Sturk, et al.
The Journal of Clinical Endocrinology and Metabolism|November 19, 2010
Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolismN J van der Zijl, G H Goossens, C C M Moors, et al.
Diabetologia|May 13, 2011
Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trialD H van Raalte, M Brands, N J van der Zijl, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 9, 2018
Influence of prednisolone on parameters of de novo lipogenesis and indices for stearoyl-CoA- and Δ6- desaturase activity in healthy males: A Post-hoc analysis of a randomized, placebo-controlled, double-blind trialI G Pranger, D H van Raalte, M Brands, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 29, 2014
Diabetes-specific emotional distress in people with Type 2 diabetes: a comparison between primary and secondary careC H Stoop, G Nefs, V J Pop, et al.
Diabetologia|February 14, 2013
Effects of induced hyperinsulinaemia with and without hyperglycaemia on measures of cardiac vagal controlM Berkelaar, E M W Eekhoff, A M C Simonis-Bik, et al.
The Journal of Clinical Endocrinology and Metabolism|November 17, 2009
Pioglitazone compared with metformin increases pericardial fat volume in patients with type 2 diabetes mellitusJ T Jonker, H J Lamb, R W van der Meer, et al.
Pageof 14